These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 24567069)

  • 41. Increased indoleamine 2,3-dioxygenase activity in type 2 diabetic nephropathy.
    Zhang Y; Ruan Y; Zhang P; Wang L
    J Diabetes Complications; 2017 Jan; 31(1):223-227. PubMed ID: 27646613
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Urinary proteomics for prediction of mortality in patients with type 2 diabetes and microalbuminuria.
    Currie GE; von Scholten BJ; Mary S; Flores Guerrero JL; Lindhardt M; Reinhard H; Jacobsen PK; Mullen W; Parving HH; Mischak H; Rossing P; Delles C
    Cardiovasc Diabetol; 2018 Apr; 17(1):50. PubMed ID: 29625564
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical impact of albuminuria in diabetic nephropathy.
    Wada T; Shimizu M; Toyama T; Hara A; Kaneko S; Furuichi K
    Clin Exp Nephrol; 2012 Feb; 16(1):96-101. PubMed ID: 21830044
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Elevated levels of renal and circulating Nop-7-associated 2 (NSA2) in rat and mouse models of diabetes, in mesangial cells in vitro and in patients with diabetic nephropathy.
    Shahni R; Gnudi L; King A; Jones P; Malik AN
    Diabetologia; 2012 Mar; 55(3):825-34. PubMed ID: 22095236
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Metabolomic and Proteomic Techniques for Establishing Biomarkers and Improving Our Understanding of Pathophysiology in Diabetic Nephropathy.
    Siwy J; Ahonen L; Magalhães P; Frantzi M; Rossing P
    Methods Mol Biol; 2020; 2067():287-306. PubMed ID: 31701458
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pattern and predictors of urine protein excretion among patients with type 2 diabetes attending a single tertiary hospital in Lagos, Nigeria.
    Bello BT; Amira CO
    Saudi J Kidney Dis Transpl; 2017; 28(6):1381-1388. PubMed ID: 29265051
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Proteomic analysis of urinary protein markers for accurate prediction of diabetic kidney disorder.
    Jain S; Rajput A; Kumar Y; Uppuluri N; Arvind AS; Tatu U
    J Assoc Physicians India; 2005 Jun; 53():513-20. PubMed ID: 16121805
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinical and pathological predictors of estimated GFR decline in patients with type 2 diabetes and overt proteinuric diabetic nephropathy.
    Mise K; Hoshino J; Ueno T; Hazue R; Sumida K; Hiramatsu R; Hasegawa E; Yamanouchi M; Hayami N; Suwabe T; Sawa N; Fujii T; Hara S; Ohashi K; Takaichi K; Ubara Y
    Diabetes Metab Res Rev; 2015 Sep; 31(6):572-81. PubMed ID: 25533683
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The implications of the detection of proteinuria and microalbuminuria in insulin and non-insulin dependent diabetes.
    Watts GF; Jasik M; Cooper ME
    Aust N Z J Med; 1995 Apr; 25(2):157-61. PubMed ID: 7605300
    [No Abstract]   [Full Text] [Related]  

  • 50. Serum LncRNA PANDAR may Act as a Novel Serum Biomarker of Diabetic Nephropathy in Patients with Type 2 Diabetes.
    Zhao C; Hu J; Wang Z; Cao ZY; Wang L
    Clin Lab; 2020 Jun; 66(6):. PubMed ID: 32538054
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Multicentre prospective validation of a urinary peptidome-based classifier for the diagnosis of type 2 diabetic nephropathy.
    Siwy J; Schanstra JP; Argiles A; Bakker SJ; Beige J; Boucek P; Brand K; Delles C; Duranton F; Fernandez-Fernandez B; Jankowski ML; Al Khatib M; Kunt T; Lajer M; Lichtinghagen R; Lindhardt M; Maahs DM; Mischak H; Mullen W; Navis G; Noutsou M; Ortiz A; Persson F; Petrie JR; Roob JM; Rossing P; Ruggenenti P; Rychlik I; Serra AL; Snell-Bergeon J; Spasovski G; Stojceva-Taneva O; Trillini M; von der Leyen H; Winklhofer-Roob BM; Zürbig P; Jankowski J
    Nephrol Dial Transplant; 2014 Aug; 29(8):1563-70. PubMed ID: 24589724
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Novel biomarkers for diabetic nephropathy].
    Araki S
    Rinsho Byori; 2014 Feb; 62(2):171-9. PubMed ID: 24800493
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Diabetic nephropathy: the proteinuria hypothesis.
    Williams ME
    Am J Nephrol; 2005; 25(2):77-94. PubMed ID: 15746541
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Clinical aspects of diabetic nephroangiopathy (author's transl)].
    Scheler F
    MMW Munch Med Wochenschr; 1977 Apr; 119(15):493-8. PubMed ID: 405565
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Multicentric validation of proteomic biomarkers in urine specific for diabetic nephropathy.
    Alkhalaf A; Zürbig P; Bakker SJ; Bilo HJ; Cerna M; Fischer C; Fuchs S; Janssen B; Medek K; Mischak H; Roob JM; Rossing K; Rossing P; Rychlík I; Sourij H; Tiran B; Winklhofer-Roob BM; Navis GJ;
    PLoS One; 2010 Oct; 5(10):e13421. PubMed ID: 20975990
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Peptiduria: a potential early predictor of diabetic kidney disease.
    Gudehithlu KP; Hart PD; Vernik J; Sethupathi P; Dunea G; Arruda JAL; Singh AK
    Clin Exp Nephrol; 2019 Jan; 23(1):56-64. PubMed ID: 30066159
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Diabetic Nephropathy: Perspective on Extracellular Vesicles.
    Lu Y; Liu D; Feng Q; Liu Z
    Front Immunol; 2020; 11():943. PubMed ID: 32582146
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Body fluid peptide and protein signatures in diabetic kidney diseases.
    Jankowski J; Schanstra JP; Mischak H
    Nephrol Dial Transplant; 2015 Aug; 30 Suppl 4():iv43-53. PubMed ID: 26209737
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Identification of urinary protein pattern in type 1 diabetic adolescents with early diabetic nephropathy by a novel combined proteome analysis.
    Meier M; Kaiser T; Herrmann A; Knueppel S; Hillmann M; Koester P; Danne T; Haller H; Fliser D; Mischak H
    J Diabetes Complications; 2005; 19(4):223-32. PubMed ID: 15993357
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Predicting diabetic nephropathy].
    Mogensen CE; Christensen CK
    Journ Annu Diabetol Hotel Dieu; 1984; ():333-49. PubMed ID: 6399537
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.